Abstract Article


Validated RP-HPLC method for estimation of Etoricoxib & Paracetamol and its applications in analysis of formulations

Prakash Sahu and Shweta Singh

ONLINE ISSN : 2456-8244



The current paper describes a reversed phase high performance liquid chromatographic method for the simultaneous estimation of Etoricoxib and Paracetamol in formulations. The separation was achieved on the LUNA C18 column 5μ (250 x 4.6 mm id), using methanol - water in the ratio 63 - 37 as the mobile phase at 1 ml/min flow rate and 237 nm as detection wavelength. The retention time of Etoricoxib and Paracetamol were 1.6 and 2.9 min respectively. The method was validated in terms of linearity, accuracy, precision, as per ICH Guidelines. The calibration curve was linear in the concentration range from 10-60 μg/ml for etoricoxib and 100-600 μg/ml for paracetamol. Percentage recovery obtained for etoricoxib and paracetamol were 99.60 % and 99.04 % respectively.


ICH, HPLC, Validation, Etoricoxib, Paracetamol, Calibration



Brautigam L, Nefflen JU, and Geisslinger G (2003) Determination of etoricoxib in human plasma by liquid chromatography-tandem mass spectrometry with electrospray ionization. J Chromatogr b 788: 309-315. Dallob A (2003) Characterization of Etoricoxib, a Novel Selective Cox-2 inhibitor, J Clin Pharmacol 43: 573 – 583. Hartman R, Abrahim A, Mao B, and Crocker LS (2003) A HPLC method for the impurity and quantitative analysis of etoricoxib. J Liq Chromatogr 26: 2551-2566. Kalsi PS (2001) Ultraviolet & Visible Spectroscopy, in Spectroscopy of organic compounds, 4th ed., pp 7-58, New age international publishers, New Delhi. Liberato BJ, Danieli CC, Marcio F, Paulo RO, and Sergio LD (2006) LC-Tandam MS/MS method for the determination of etoricoxib in human plasma and pharmaceutical formulations. J Liq Chromatogr 29: 123-135. Maheshwar G, Subramanian GS, Karthik A, Musmade P, Gunjupalli K, and Uupa N (2007) High performance liquid chromatograpy method for the determination of etoricoxib in the bulk drug and in pharmaceutical dosage form. J Planar Chromatogr-Modern TLC 20: 335- 339. Mandal U, Senthil RD, Bose A, Gowda KV, and Pal TK (2006) HPLC method for analysis of etoricoxib in human plasma. J Pharm Sci 68: 485-489. Patel HM, Suhagia BN, Shah SA, and Rathod IS (2007) Determination of etoricoxib in pharmaceutical formulation by HPLC method. J Pharm Sci 69: 703-704. Patrignani P (2003) Clinical Pharmacology of Etoricoxib: A Novel selective Cox Inhibitors. Expert Opin Pharmacother 4: 265 – 284. Pattan SR, Jamdas SG, Godgel RK, Dighe NS, Daithankari AV, Nirmal SA, and Pai MG (2006) RP-HPLC method for simultaneous estimation of paracetamol and etoricoxib from bulk tablets, J Liq Chromatogr 20: 112-120. Sethi PD (2007) HPLC quantitative analysis of pharmaceutical formulation, 5th ed. CBS Publishers & Distributers, New Delhi Venkata VA, Menon CA, Addepalli VR, and Mullangi R (2005) Simultaneous quantitation of etoricoxib, salicylic acid, valdecoxib, ketoprofen, nimesulide and celecoxib in plasma by high-performance liquid chromatography with UV detection. J Biomed Anal 21: 125-132. Werner U, Werner D, Hinz B, Lambrecht C, and Brune K (2004) Liquid chromatographymass spectrometry method for the quantification of both etoricoxib and valdecoxib in human plasma. J Biomed Chromatopgr 19:113-118. Willard HH, Merritt LL Jr, and Settle FA Jr (2001) An Introduction to Instrumental Methods, in Instrumental methods of analysis, 7th ed., pp 1-12, CBS Publisher & Distributors, Delhi.